MGMT-UNMETHYLATED GLIOBLASTOMA
Clinical trials for MGMT-UNMETHYLATED GLIOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new MGMT-UNMETHYLATED GLIOBLASTOMA trials appear
Sign up with your email to follow new studies for MGMT-UNMETHYLATED GLIOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope in fight against aggressive brain cancer
Disease control Recruiting nowThis study is testing whether adding an investigational drug called ruxolitinib to the standard treatment (radiation and chemotherapy) helps people with newly diagnosed glioblastoma live longer. About 190 adults will be randomly assigned to receive either the standard treatment a…
Matched conditions: MGMT-UNMETHYLATED GLIOBLASTOMA
Phase: PHASE2 • Sponsor: Baptist Health South Florida • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
New brain cancer combo aims to outsmart Tumor's defenses
Disease control Recruiting nowThis study is testing whether adding an experimental drug called WP1066 to standard radiation therapy can better control a fast-growing type of brain cancer called glioblastoma. The drug is designed to block a specific pathway that helps the tumor grow and hide from the body's im…
Matched conditions: MGMT-UNMETHYLATED GLIOBLASTOMA
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Scientists test 'Living Drug' to fight deadly brain tumors
Disease control Recruiting nowThis early-stage study is testing a new personalized treatment for adults with a specific type of recurrent brain cancer called glioblastoma. Doctors take a patient's own immune cells, genetically modify them in a lab to better target the cancer, and then infuse them back into th…
Matched conditions: MGMT-UNMETHYLATED GLIOBLASTOMA
Phase: PHASE1 • Sponsor: Hideho Okada, MD, PhD • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New Virus-Based therapy enters human trials for deadly brain cancer
Disease control Recruiting nowThis study is testing whether adding two new drugs, DB107-RRV and DB107-FC, to standard brain cancer treatment helps patients live longer without their cancer worsening. The trial will enroll 70 adults with newly diagnosed aggressive brain tumors who are having surgery. Researche…
Matched conditions: MGMT-UNMETHYLATED GLIOBLASTOMA
Phase: PHASE1, PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC